TGM2 and celiac disease: Although this study was limited by its single-center design and the lack of confirmatory endoscopic biopsy for celiac disease in all subjects who were anti-TTG positive, it provides valuable baseline evidence and serves as a foundation for future multicenter, longitudinal research.